Hosenkoside F has shown potential in anti-inflammatory applications, particularly in the inhibition of nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated microglial cells. This suggests its possible use in managing neuroinflammatory conditions. It may also contribute to the development of therapeutic agents targeting chronic inflammation and related degenerative diseases. Research is ongoing to explore its bioavailability and mechanism of action in cellular pathways.